MODERNA, INC. MODERNA CONSIDERS PRICE OF $110-$130 FOR COVID-19 VACCINE - WSJ
Moderna Considers Price Of $110-$130 For Covid-19 Vaccine - Wsj…
January 09, 2023 at 01:42 pm EST
Share
Share
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.7 USD | +1.58% |
|
+6.62% | +29.79% |
| 03:17pm | Investors need more than PPI to make up their minds |  |
| 11:26am | ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor... | |
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
- revenues from collaboration agreements (0.3%).
At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development.
Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
125.7
USD
Average target price
138.5
USD
Spread / Average Target
+10.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.79% | 48.16B | |
| -1.20% | 41.73B | |
| +43.45% | 41.03B | |
| -5.26% | 28.77B | |
| +10.17% | 25.59B | |
| -22.92% | 18.96B | |
| +7.98% | 12.92B | |
| +29.14% | 12.03B | |
| -1.89% | 11.77B | |
| +21.59% | 11.73B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna Considers Price Of $110-$130 For Covid-19 Vaccine - Wsj…